Profile data is unavailable for this security.
About the company
Humanwell Healthcare (Group) Co., Ltd is a China-based company principally engaged in research and development, manufacture and distribution of medical and pharmaceutical products. The Company’s products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The Company also provides medical instruments. The Company distributes its products in both domestic market and to overseas markets.
- Revenue in CNY (TTM)24.67bn
- Net income in CNY1.96bn
- Incorporated1993
- Employees17.68k
- LocationHumanwell Healthcare Group Co LtdNo. 666 Gaoxin AvenueDonghu High-Tech DistrictWUHAN 430075ChinaCHN
- Phone+86 2 787597232
- Fax+86 2 787596393
- Websitehttp://www.humanwell.com.cn
More ▼
Mergers & acquisitions
| Acquired company | 600079:SHH since announced | Transaction value |
|---|---|---|
| PAION AG | -22.62% | -- |
Data delayed at least 15 minutes, as of Mar 13 2024 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Allist Pharmaceuticals Co Ltd | 1.62bn | 487.02m | 27.94bn | 870.00 | 57.36 | 7.66 | -- | 17.23 | 1.08 | 1.08 | 3.60 | 8.10 | 0.4513 | 1.96 | 9.77 | 1,863,318.00 | 13.56 | -6.70 | 14.46 | -7.38 | 94.94 | 96.63 | 30.04 | -49.48 | 8.50 | -- | 0.0006 | -- | 49.22 | 152.37 | 614.22 | -- | 152.72 | -- |
| Gan & Lee Pharmaceuticals | 2.61bn | 386.85m | 29.73bn | 4.48k | 74.40 | 2.72 | -- | 11.39 | 0.6726 | 0.6726 | 4.52 | 18.38 | 0.234 | 0.8926 | 10.97 | 582,412.30 | 3.47 | 8.30 | 3.71 | 8.83 | 72.29 | 85.39 | 14.83 | 26.44 | 7.74 | -- | 0.0006 | 13.65 | 52.31 | 1.78 | 177.37 | -18.30 | 1.50 | -- |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 8.22bn | 986.71m | 31.15bn | 4.62k | 27.26 | 4.08 | -- | 3.79 | 1.28 | 1.28 | 10.70 | 8.58 | 0.8066 | 3.13 | 3.81 | 1,780,107.00 | 9.50 | 8.96 | 14.09 | 12.80 | 43.04 | 40.82 | 11.78 | 10.67 | 1.54 | -- | 0.1256 | 56.93 | -0.3266 | 5.28 | 14.49 | 11.93 | -4.33 | 42.22 |
| Humanwell Healthcare Group Co Ltd | 24.67bn | 1.96bn | 33.06bn | 17.68k | 16.78 | 1.89 | -- | 1.34 | 1.21 | 1.21 | 15.25 | 10.73 | 0.6833 | 3.80 | 2.77 | 1,395,473.00 | 7.21 | 6.20 | 13.29 | 12.72 | 45.02 | 42.82 | 10.55 | 9.84 | 1.20 | 31.56 | 0.3293 | 18.87 | 9.79 | 5.65 | -14.07 | -- | 8.25 | -- |
| Autobio Diagnostics Co Ltd | 4.50bn | 1.30bn | 33.43bn | 5.54k | 25.49 | 3.77 | -- | 7.43 | 2.24 | 2.24 | 7.74 | 15.11 | 0.4066 | 2.08 | 4.27 | 811,768.30 | 11.81 | 12.59 | 14.50 | 15.79 | 64.76 | 61.62 | 29.04 | 26.96 | 2.81 | -- | 0.1035 | 46.40 | 0.0457 | 18.15 | 4.28 | 16.70 | 17.03 | 11.28 |
| Hubei Jumpcan Pharmaceutical Co Ltd | 9.67bn | 2.99bn | 37.92bn | 5.23k | 12.62 | 2.65 | -- | 3.92 | 3.26 | 3.26 | 10.54 | 15.51 | 0.5504 | 3.66 | 4.60 | 1,848,716.00 | 17.05 | 16.23 | 22.52 | 20.88 | 79.76 | 82.64 | 30.98 | 24.42 | 3.01 | -- | 0.1275 | 41.76 | 7.32 | 6.02 | 30.04 | 10.83 | -14.70 | 1.11 |
Data as of Mar 13 2024. Currency figures normalised to Humanwell Healthcare Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
13.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Sep 2023 | 39.69m | 2.72% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 33.82m | 2.32% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 23.79m | 1.63% |
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 19.03m | 1.31% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 18.73m | 1.29% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2023 | 14.86m | 1.02% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 13.86m | 0.95% |
| GF Fund Management Co., Ltd.as of 30 Sep 2023 | 12.83m | 0.88% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2023 | 10.70m | 0.73% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 10.37m | 0.71% |
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
